Cite
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer.
MLA
Pecci, Valeria, et al. “Targeting of H19/Cell Adhesion Molecules Circuitry by GSK-J4 Epidrug Inhibits Metastatic Progression in Prostate Cancer.” Cancer Cell International, vol. 24, no. 1, Feb. 2024, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12935-024-03231-6.
APA
Pecci, V., Troisi, F., Aiello, A., De Martino, S., Carlino, A., Fiorentino, V., Ripoli, C., Rotili, D., Pierconti, F., Martini, M., Porru, M., Pinto, F., Mai, A., Bassi, P. F., Grassi, C., Gaetano, C., Pontecorvi, A., Strigari, L., Farsetti, A., & Nanni, S. (2024). Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer. Cancer Cell International, 24(1), 1–17. https://doi.org/10.1186/s12935-024-03231-6
Chicago
Pecci, Valeria, Fabiola Troisi, Aurora Aiello, Sara De Martino, Angela Carlino, Vincenzo Fiorentino, Cristian Ripoli, et al. 2024. “Targeting of H19/Cell Adhesion Molecules Circuitry by GSK-J4 Epidrug Inhibits Metastatic Progression in Prostate Cancer.” Cancer Cell International 24 (1): 1–17. doi:10.1186/s12935-024-03231-6.